Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1

PaperCitations, authors & open-access status

miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 120 citations, 2016 year and closed oa status.

120
Citations
2016
Year
closed
OA Status

Related on ScholarIQ

Jianfei Huang
Author
Biomedicine & Pharmacotherapy
Journal
MicroRNA in disease regulation
Topic
MicroRNA in disease regulation
Topic
Lung Cancer Treatments and Mutations
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
470M+ articles · free account